Director Stephen Luczo bought $3.7 mil of AT&T(T) at $37.60 on Feb.4. It was Luczo's -- who is also Chairman of the Board at Seagate Technology(STX) -- first open market purchase of AT&T shares since becoming a director in November. Luczo's history as a...
A Mellanox (MLNX) insider bought $2.2 million of the Israeli chip designer as fears China will block a proposed merger with Nvidia Corp (NVDA) pushed the price of MLNX well below the buyout price. Stephen Sanghi, a director of Sunnyvale-based Mellanox since February...
BlueLinx insiders bought after their company's stock price was cut in half after a surprise revenue decline. On Nov. 5, BXC closed at $31. Then came an earnings report showing a significant revenue decline. On Thursday morning BlueLinx (BXC) traded as low as $13.47...
Protagonist Therapeutics insiders bought on Tuesday as their company's stock plummeted after preliminary data appeared to cast doubt on Protagonist's (PGTX) key drug. On Monday, the company presented an initial look at preliminary results from the TRANSCEND Ph2 open-label study of PTG-300 (hepcidin...
Cigna Insider Buying is a rarity. Only one corporate insider had bought shares of the giant health insurer on the open market since 2003. That changed dramatically on Monday, as Cigna (CI) CEO David Cordani disclosed the purchase of 32,509 shares of his company's stock at $155.17....
On Dec. 23, Nierenberg Investment filed a 13D/A on Houston Wire and Cable (HWCC). The investment adviser expressed frustration that the market value of its long-held position in the micro-cap has "widened substantially over the last two years." The filing amended a 13D...
Insiders buy market crashes, backing up the truck if their shares get cheap enough. The smartest fund managers can make their year -- even careers -- acquiring great companies at phenomenal bargains during market crashes. True market crashes are rare--black swans. But garden variety "panics" occur fairly...
Solid Biosciences' private placement featured investments by an all star list of top biotech institutional investors. Cambridge-based Solid Biosciences (SLDB) trades at 1/3 of its January 2018 IPO value. But based on the A-list biotech investors buying shares in the company's July 26 $60...
On Friday, Engaged Capital LLC, a big holder of Hain Celestial Group, announced it bought $19 million more of HAIN, even though the stock had popped 10% over the previous couple days. Often, corporate insiders buy into share weakness...
Twenty-two minutes after regular market hours closed on July 2, an Orbimed Advisors Form 4 relating to Corvus Pharmaceuticals Inc (CRVS) was posted on the SEC's website. The hedge fund, a 10%+ holder and insider in CRVS, disclosed that between June 27 and July 1 it...